China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion - ResearchAndMarkets.com

The "China In-Vitro Diagnostics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The China in-vitro diagnostics market is poised to grow by $6.93 billion during 2020-2024 progressing at a CAGR of 17% during the forecast period.

The market is driven by the increase in incidences of chronic and infectious diseases, geriatric population in China and increase in adoption of POC testing.

The report offers an up-to-date analysis regarding the current china market scenario, latest trends and drivers, and the overall market environment. The China in-vitro diagnostics market analysis includes the end-user segment and geographical landscapes.

This study identifies the healthcare infrastructure expansion as one of the prime reasons driving the China in-vitro diagnostics market growth during the next few years. Also, continuous advances in IVD procedures and companion diagnostics will lead to sizable demand in the market.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading China in-vitro diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Autobio Diagnostics Co. Ltd., Bioptik Technology Inc., Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, and Sysmex Corp.

Also, the China in-vitro diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Key Topics Covered:

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019-2024

Five Forces Analysis

• Five Forces Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Application

• Market segments
• Comparison by Application
• Immunochemistry - Market size and forecast 2019-2024
• Tissue diagnostics - Market size and forecast 2019-2024
• Molecular diagnostics - Market size and forecast 2019-2024
• Hematology - Market size and forecast 2019-2024
• Others - Market size and forecast 2019-2024
• Market opportunity by Application

Market Segmentation by End-user

• Market segments
• Comparison by End user
• Hospitals - Market size and forecast 2019-2024
• Homecare - Market size and forecast 2019-2024
• Research institutes - Market size and forecast 2019-2024
• Independent laboratories - Market size and forecast 2019-2024
• Market opportunity by End user

Customer Landscape

• Overview
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Abbott Laboratories
• Agilent Technologies Inc.
• Autobio Diagnostics Co. Ltd.
• Bioptik Technology Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Siemens Healthineers AG
• Sysmex Corp.

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/jpx0yk

View source version on businesswire.com: https://www.businesswire.com/news/home/20210304005709/en/